Effects of the Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 on the Tumor Vasculature: Implications for Clinical Imaging

Cancer Research - United States
doi 10.1158/0008-5472.can-08-1044
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

The Dual PI3K/mTOR Inhibitor, NVP-BEZ235, Is Efficacious Against Follicular Lymphoma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important?

Frontiers in Oncology
Cancer ResearchOncology
2018English

Temsirolimus, an Inhibitor of Mammalian Target of Rapamycin

Clinical Cancer Research
Cancer ResearchOncology
2008English

The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Enhances Nab-Paclitaxel Antitumor Response in Experimental Gastric Cancer

International Journal of Oncology
Cancer ResearchOncology
2013English

Shiga Toxin 1-Induced Proinflammatory Cytokine Production Is Regulated by the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2009English

NVP-BEZ235, a Novel Dual PI3K/mTOR Inhibitor, Enhances the Radiosensitivity of Human Glioma Stem Cells in Vitro

Acta Pharmacologica Sinica
MedicinePharmacology
2013English

Interferon Α-Induced Apoptosis in Tumor Cells Is Mediated Through the Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Signaling Pathway

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Phosphoinositide-3 Kinase/Protein Kinase-B/Mammalian Target of Rapamycin Pathway in Psoriasis Pathogenesis. A Potential Therapeutic Target?

Acta Dermato-Venereologica
DermatologyMedicine
2014English

Ku-0063794 Is a Specific Inhibitor of the Mammalian Target of Rapamycin (mTOR)

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy